Skip to main content

Table 2 Significant profiles selected by BSM

From: Modelling gene expression profiles related to prostate tumor progression using binary states

Profile

Genes

%

Folds

pValue

qValue

Type

−1.-1.-1.1

10

4.7

110

4.55E-06

0.09129

Oncogene (Late)

−1.-1.1.1

1

0.5

Inf

0.00E+00

0.00100

Oncogene

−1.0.-1.1

2

0.9

10

1.01E-05

0.19985

Oncogene

−1.0.1.-1

25

11.6

1563

8.00E-07

0.01693

2 t

−1.0.1.0

29

13.5

199

7.30E-06

0.14565

Oncogene

−1.0.1.1

6

2.8

600

5.00E-07

0.01096

Oncogene

−1.1.0.1

2

0.9

42

2.40E-06

0.04871

Oncogene (Early)

−1.1.1.-1

13

6.0

Inf

0.00E+00

0.00100

2 t

−1.1.1.0

20

9.3

3333

3.00E-07

0.00699

Oncogene (Early)

−1.1.1.1

6

2.8

6000

5.00E-08

0.00200

Oncogene (Early)

1.-1.-1.-1

6

2.8

6000

5.00E-08

0.00200

TSG (Early)

1.-1.-1.0

16

7.4

2000

4.00E-07

0.00898

TSG (Early)

1.-1.-1.1

8

3.7

Inf

0.00E+00

0.00100

2 t

1.-1.0.-1

6

2.8

222

1.35E-06

0.02784

TSG (Early)

1.0.-1.-1

5

2.3

625

4.00E-07

0.00898

TSG

1.0.-1.0

19

8.8

184

5.15E-06

0.10314

TSG

1.0.-1.1

6

2.8

231

1.30E-06

0.02686

2 t

1.1.1.-1

35

16.3

412

4.25E-06

0.08548

TSG (Late) / MSG

  1. Folds is the number of times the corresponding stage-state profile was observed in Tomlins dataset relative to the permuted dataset or “Inf” when not observed in permuted dataset.